Switch to:
Allergan PLC (NYSE:AGN)
EV/EBITDA
135.09 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Allergan PLC's enterprise value is $175,462 Mil. Allergan PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $1,299 Mil. Therefore, Allergan PLC's EV/EBITDA ratio for today is 135.09.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Allergan PLC's stock price is $331.15. Allergan PLC's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-8.28. Therefore, Allergan PLC's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Allergan PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=175462.042/1298.9
=135.09

Allergan PLC's current Enterprise Value is $175,462 Mil.
Allergan PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was 643.9 (Jun. 2014 ) + -80.4 (Sep. 2014 ) + 270.9 (Dec. 2014 ) + 464.5 (Mar. 2015 ) = $1,299 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Allergan PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=331.15/-8.279
=

Allergan PLC's share price for today is $331.15.
Allergan PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was 0.28 (Jun. 2014 ) + -3.95 (Sep. 2014 ) + -2.759 (Dec. 2014 ) + -1.85 (Mar. 2015 ) = $-8.28.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Allergan PLC Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda 8.11-21.926.715.6310.4711.718.4218.1157.9754.35

Allergan PLC Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda 18.1121.0543.3939.3457.9738.1022.0548.2654.35124.92
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK